| scholarly article | Q13442814 |
| P50 | author | Francois Rousset | Q55175960 |
| Thierry Defrance | Q62669243 | ||
| Jacques Banchereau | Q55097670 | ||
| P2093 | author name string | D H Hsu | |
| K W Moore | |||
| E Garcia | |||
| R Kastelein | |||
| N Vezzio | |||
| C Péronne | |||
| P2860 | cites work | Evidence for compartmentalization of functional subsets of CD2+ T lymphocytes in atopic patients | Q68090119 |
| Regulation of human IgE synthesis. I. Human IgE synthesis in vitro is determined by the reciprocal antagonistic effects of interleukin 4 and interferon-gamma | Q68411976 | ||
| Activation of human B lymphocytes through CD40 and interleukin 4 | Q69099068 | ||
| Two types of murine helper T cell clone. II. Delayed-type hypersensitivity is mediated by TH1 clones | Q70030269 | ||
| B cell growth-promoting activity of recombinant human interleukin 4 | Q70349955 | ||
| Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRFI | Q24312126 | ||
| Molecular cloning and expression of a human B-cell growth factor gene in Escherichia coli | Q28300438 | ||
| Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins | Q29547534 | ||
| TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties | Q29547848 | ||
| Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones | Q29622840 | ||
| CD40 and IgE: synergism between anti-CD40 monoclonal antibody and interleukin 4 in the induction of IgE synthesis by highly purified human B cells | Q30442717 | ||
| Effect of tumor necrosis factor alpha on mitogen-activated human B cells | Q36353905 | ||
| Interleukin 10, a novel B cell stimulatory factor: unresponsiveness of X chromosome-linked immunodeficiency B cells | Q36354177 | ||
| Lymphokine-mediated regulation of the proliferative response of clones of T helper 1 and T helper 2 cells | Q36355239 | ||
| Detection of human cytokine-secreting cells in distinct anatomical compartments | Q37338075 | ||
| Polyclonal Ig production after Epstein-Barr virus infection of human lymphocytes in vitro | Q40068213 | ||
| Cytokine-induced proliferation and immunoglobulin production of human B lymphocytes triggered through their CD40 antigen | Q41694124 | ||
| Long-Term Human B Cell Lines Dependent on Interleukin-4 and antibody to CD40 | Q41700086 | ||
| Expression of interleukin-10 activity by Epstein-Barr virus protein BCRF1. | Q41715014 | ||
| Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI. | Q41731198 | ||
| Interleukin 4 inhibits the proliferation but not the differentiation of activated human B cells in response to interleukin 2. | Q42111797 | ||
| Cloned and expressed human Fc receptor for IgG mediates anti-CD3-dependent lymphoproliferation | Q42123524 | ||
| The short unique region of the B95-8 Epstein-Barr virus genome | Q42129046 | ||
| Accumulation of Th-2-like helper T cells in the conjunctiva of patients with vernal conjunctivitis | Q44570503 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | interleukins | Q194908 |
| interleukin 10 | Q423698 | ||
| lymphocyte | Q715347 | ||
| growth factor activity | Q14820601 | ||
| P304 | page(s) | 1890-1893 | |
| P577 | publication date | 1992-03-01 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes | |
| P478 | volume | 89 |
| Q35295519 | 2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated disruption of the CD40 ligand-induced activation of primary human B cells |
| Q56780465 | 3D modeling and molecular dynamics simulation of an immune-regulatory cytokine, interleukin-10, from the Indian major carp, Catla catla |
| Q93382039 | A CD4+ T cell population expanded in lupus blood provides B cell help through interleukin-10 and succinate |
| Q54791571 | A Chinese herbal medicine, fu-ling, regulates interleukin-10 production by murine spleen cells. |
| Q35382266 | A Kaposi's sarcoma-associated herpesvirus-encoded ortholog of microRNA miR-155 induces human splenic B-cell expansion in NOD/LtSz-scid IL2Rγnull mice |
| Q81787772 | A functional polymorphism in the IL-10 promoter influences the response after vaccination with HBsAg and hepatitis A |
| Q24530097 | A model of the ternary complex of interleukin-10 with its soluble receptors |
| Q84748661 | A new role for interleukin-10 in immune regulation |
| Q24563839 | A receptor for interleukin 10 is related to interferon receptors |
| Q36375705 | A single amino acid determines the immunostimulatory activity of interleukin 10. |
| Q70623844 | A subset of anti-CD21 antibodies promote the rescue of germinal center B cells from apoptosis |
| Q55260575 | APVO210: A Bispecific Anti-CD86-IL-10 Fusion Protein (ADAPTIR™) to Induce Antigen-Specific T Regulatory Type 1 Cells. |
| Q37168674 | Ablation of STAT3 in the B Cell Compartment Restricts Gammaherpesvirus Latency In Vivo |
| Q91825063 | Abnormal B-Cell Subset and Blimp-1-Mediated Humoral Responses Associated With Visceral Leishmaniasis Pathogenesis |
| Q39508890 | Abnormal CD40 ligand (CD154) expression in human immunodeficiency virus-infected children |
| Q27326637 | Abortive T follicular helper development is associated with a defective humoral response in Leishmania infantum-infected macaques |
| Q39808469 | Absence of IgD-CD27(+) memory B cell population in X-linked hyper-IgM syndrome |
| Q35759195 | Absence of the Adaptor Protein PEA-15 Is Associated with Altered Pattern of Th Cytokines Production by Activated CD4+ T Lymphocytes In Vitro, and Defective Red Blood Cell Alloimmune Response In Vivo |
| Q33901807 | Activated B cells from patients with common variable immunodeficiency proliferate and synthesize immunoglobulin |
| Q37422374 | Activation of human B cells by the agonist CD40 antibody CP-870,893 and augmentation with simultaneous toll-like receptor 9 stimulation |
| Q27478400 | Activation/modulation of adaptive immunity emerges simultaneously after 17DD yellow fever first-time vaccination: is this the key to prevent severe adverse reactions following immunization? |
| Q73191967 | Allergen-induced cytokine secretion in relation to atopic symptoms and immunoglobulin E and immunoglobulin G subclass antibody responses |
| Q52732451 | Alterations in T-lymphocyte sub-set profiles and cytokine secretion by PBMC of systemic lupus erythematosus patients upon in vitro exposure to organochlorine pesticides. |
| Q71815059 | Altered CD40 ligand induction in tolerant T lymphocytes |
| Q77394194 | An anti-inflammatory role for interleukin-11 in established murine collagen-induced arthritis |
| Q74074329 | Analysis of neonatal T cell and antigen presenting cell functions |
| Q36537312 | Analysis of single nucleotide polymorphisms in the promoter region of interleukin-10 by denaturing high-performance liquid chromatography. |
| Q36089541 | Anti-CD180 (RP105) activates B cells to rapidly produce polyclonal Ig via a T cell and MyD88-independent pathway |
| Q34545880 | Antibody production and in vitro behavior of CD27-defined B-cell subsets: persistent hepatitis C virus infection changes the rules. |
| Q94547378 | Aqueous humour cytokines profiles in eyes with Coats disease and the association with the severity of the disease |
| Q61971730 | Association of IL-10 genotype with sudden infant death syndrome |
| Q34719080 | Association of IL-4 and IL-10 maternal haplotypes with immune responses to P. falciparum in mothers and newborns |
| Q46647664 | Association of Interleukin-2-330T/G and Interleukin-10-1082A/G Genetic Polymorphisms with B-Cell Non-Hodgkin Lymphoma in a Cohort of Egyptians |
| Q37189357 | Association of estrogen receptor alpha gene polymorphisms with cytokine genes expression in systemic lupus erythematosus. |
| Q51111004 | Association of extended interleukin-10 promoter haplotypes with disease susceptibility and manifestations in German patients with systemic lupus erythematosus. |
| Q37232037 | Association of interleukin-10 A-592C polymorphism in Taiwanese children with Kawasaki disease |
| Q53567834 | Association of interleukin-10 gene polymorphisms with severe generalized chronic periodontitis. |
| Q44292445 | Association of promoter genetic variants in interleukin-10 and Kawasaki disease with coronary artery aneurysms. |
| Q78675653 | Association tests with systemic lupus erythematosus (SLE) of IL10 markers indicate a direct involvement of a CA repeat in the 5' regulatory region |
| Q50856763 | Autocrine IL-10 promotes human B-cell differentiation into IgM- or IgG-secreting plasmablasts. |
| Q36362252 | B cell activation via CD40 is required for specific antibody production by antigen-stimulated human B cells |
| Q33615168 | B cell-intrinsic signaling through IL-21 receptor and STAT3 is required for establishing long-lived antibody responses in humans |
| Q81021754 | B cells alter the phenotype and function of follicular-homing CXCR5+ T cells |
| Q41479099 | B cells regulate expression of CD40 ligand on activated T cells by lowering the mRNA level and through the release of soluble CD40. |
| Q39579254 | B-lymphocyte proliferation during bovine leukemia virus-induced persistent lymphocytosis is enhanced by T-lymphocyte-derived interleukin-2. |
| Q38194927 | B-type suppression: a role played by "regulatory B cells" or "regulatory plasma cells"? |
| Q35810521 | Beneficial Effects of cART Initiated during Primary and Chronic HIV-1 Infection on Immunoglobulin-Expression of Memory B-Cell Subsets |
| Q56987728 | Biological properties of interleukin 10 |
| Q90701028 | Biology and therapeutic potential of interleukin-10 |
| Q36855432 | Blood concentrations of the cytokines IL-1beta, IL-6, IL-10, TNF-alpha and IFN-gamma during experimentally induced swine dysentery |
| Q51877720 | Bone marrow findings in HIV-positive patients with Kaposi sarcoma herpesvirus-associated multicentric Castleman disease. |
| Q40071467 | CD11c+ T-bet+ memory B cells: Immune maintenance during chronic infection and inflammation? |
| Q37635350 | CD14brightCD16+ intermediate monocytes are induced by interleukin-10 and positively correlate with disease activity in rheumatoid arthritis. |
| Q34204228 | CD1d(hi)CD5+ B cells expanded by GM-CSF in vivo suppress experimental autoimmune myasthenia gravis |
| Q36849492 | CD28-B7 interaction modulates short- and long-lived plasma cell function. |
| Q28295960 | CD40 and the effect of anti-CD40-binding on human multiple myeloma clonogenicity |
| Q36243258 | CD40 engagement triggers switching to IgA1 and IgA2 in human B cells through induction of endogenous TGF-beta: evidence for TGF-beta but not IL-10-dependent direct S mu-->S alpha and sequential S mu-->S gamma, S gamma-->S alpha DNA recombination |
| Q42754645 | CD40 expression in Hodgkin's disease |
| Q30453877 | CD40 ligand expression is defective in a subset of patients with common variable immunodeficiency |
| Q35147016 | CD40 ligand is a critical effector of Epstein-Barr virus in host cell survival and transformation |
| Q41134276 | CD40-CD40 ligand: a multifunctional receptor-ligand pair. |
| Q41404432 | CD40/CD40 ligand interactions in normal, reactive and malignant lympho-hematopoietic tissues |
| Q59812771 | CKD-506, a novel HDAC6-selective inhibitor, improves renal outcomes and survival in a mouse model of systemic lupus erythematosus |
| Q34880596 | Carcinogenicity testing of IL-10: principles and practicalities |
| Q40350571 | Characterization of main cytokine sources from the innate and adaptive immune responses following primary 17DD yellow fever vaccination in adults. |
| Q36827309 | Characterization of plasmablasts in the blood of HIV-infected viremic individuals: evidence for nonspecific immune activation |
| Q34311415 | Characterization of recombinant extracellular domain of human interleukin-10 receptor |
| Q33768109 | Cholera toxin, LT-I, LT-IIa and LT-IIb: the critical role of ganglioside binding in immunomodulation by type I and type II heat-labile enterotoxins |
| Q77704355 | Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation |
| Q39153232 | Circulating CXCR5+CD4+ T cells assist in the survival and growth of primary diffuse large B cell lymphoma cells through interleukin 10 pathway |
| Q41622831 | Clinical severity of visceral leishmaniasis is associated with changes in immunoglobulin g fc N-glycosylation |
| Q33398637 | Clinical significance of serum cytokine levels and thrombopoietic markers in childhood idiopathic thrombocytopenic purpura |
| Q71716944 | Clinical, hematologic, and immunologic effects of interleukin-10 in humans |
| Q28509977 | Cloning and characterization of mouse IL-22 binding protein |
| Q33959343 | Collapse of the CD27+ B-cell compartment associated with systemic plasmacytosis in patients with advanced melanoma and other cancers |
| Q52330492 | Combined Analysis of Interleukin-10 Gene Polymorphisms and Protein Expression in Children With Cerebral Palsy. |
| Q90560580 | Combining immunoprofiling with machine learning to assess the effects of adjuvant formulation on human vaccine-induced immunity |
| Q94569692 | Comparative Sequence Analysis of Historic and Current Porcine Rotavirus C Strains and Their Pathogenesis in 3-Day-Old and 3-Week-Old Piglets |
| Q42598575 | Conformational changes mediate interleukin-10 receptor 2 (IL-10R2) binding to IL-10 and assembly of the signaling complex |
| Q36508931 | Cooperative signaling through the signal transducer and activator of transcription 3 and nuclear factor-{kappa}B pathways in subtypes of diffuse large B-cell lymphoma |
| Q33438392 | Correlation of cytokine level with the severity of severe fever with thrombocytopenia syndrome |
| Q33792418 | Could the airway epithelium play an important role in mucosal immunoglobulin A production? |
| Q24674762 | Crystal structure of human interleukin-10 at 1.6 A resolution and a model of a complex with its soluble receptor |
| Q27732561 | Crystal structure of interleukin-10 reveals the functional dimer with an unexpected topological similarity to interferon gamma |
| Q39111609 | Cutting Edge: IL-10 Is Essential for the Generation of Germinal Center B Cell Responses and Anti-Plasmodium Humoral Immunity |
| Q52861960 | Cytokine Expression by T Follicular Helper Cells. |
| Q71788270 | Cytokine Gene and CD25 Antigen Expression by Peripheral Blood T Cells from Patients with Primary Sjögren's Syndrome |
| Q58192318 | Cytokine IL-6 and IL-10 as Biomarkers in Systemic Lupus Erythematosus |
| Q24800020 | Cytokine and immunoglobulin production by PWM-stimulated peripheral and tumor-infiltrating lymphocytes of undifferentiated nasopharyngeal carcinoma (NPC) patients |
| Q45936003 | Cytokine and molecular analyses of intraocular lymphoma. |
| Q42489806 | Cytokine expression and regulation of human plasma cells: disappearance of interleukin-10 and persistence of transforming growth factor-beta 1. |
| Q35743839 | Cytokine homologs of human gammaherpesviruses |
| Q36362064 | Cytokine mRNA expression during an in vitro response of human B lymphocytes: kinetics of B cell tumor necrosis factor alpha, interleukin (IL)6, IL-10, and transforming growth factor beta 1 mRNAs |
| Q54375228 | Cytokine mRNA profile of alveolar T lymphocytes and macrophages in patients with systemic sclerosis suggests a local Tr1 response. |
| Q40966517 | Cytokine mediated effects in mucosal immunity |
| Q43437276 | Cytokine profiles of cells extracted from humans with periodontal diseases |
| Q34233101 | Cytokine responses in gnotobiotic pigs after infection with virulent or attenuated human rotavirus. |
| Q77225004 | Cytokine secretion: clinical relevance of immunosuppression in non-small cell lung cancer |
| Q37589643 | Cytokine-Mediated Regulation of Plasma Cell Generation: IL-21 Takes Center Stage. |
| Q40454403 | Cytokine/cytokine receptor gene expression in childhood acute lymphoblastic leukemia: correlation of expression and clinical outcome at first disease recurrence. |
| Q41754977 | Cytokines and prostaglandins in immune homeostasis and tissue destruction in periodontal disease. |
| Q40841539 | Cytokines and their role as growth factors and in regulation of immune responses |
| Q37387713 | Cytokines in Sjögren's syndrome |
| Q38211700 | Cytokines in common variable immunodeficiency as signs of immune dysregulation and potential therapeutic targets - a review of the current knowledge |
| Q80962995 | Cytokines in pancreatic carcinoma: correlation with phenotypic characteristics and prognosis |
| Q36659210 | Cytokines in systemic lupus erythematosus |
| Q90312378 | Cytokines in the Germinal Center Niche |
| Q36081394 | DSHP: a "power bar" for sustained immune responses? |
| Q73731314 | Design and analysis of an engineered human interleukin-10 monomer |
| Q57350977 | Development of lupus‐related side‐effects in patients with early RA during sulphasalazine treatment—the role of IL‐10 and HLA |
| Q30433488 | Development of murine lupus involves the combined genetic contribution of the SLAM and FcgammaR intervals within the Nba2 autoimmune susceptibility locus |
| Q45227439 | Dietary n-3 polyunsaturated fatty acids suppress splenic CD4(+) T cell function in interleukin (IL)-10(-/-) mice. |
| Q35901914 | Differential Effects of Escherichia coli Nissle and Lactobacillus rhamnosus Strain GG on Human Rotavirus Binding, Infection, and B Cell Immunity |
| Q30279164 | Differential Effects of Tacrolimus versus Sirolimus on the Proliferation, Activation and Differentiation of Human B Cells |
| Q44339451 | Differential alteration of functions of rat peritoneal macrophages responsive to endogenous opioid peptide endomorphin-1. |
| Q71993263 | Differential correlation between interleukin patterns in disseminated and chronic human paracoccidioidomycosis |
| Q72508353 | Differential effects of gangliosides on human IgE and IgG4 production |
| Q40691150 | Differential regulation of interleukin-10 production by genetic and environmental factors--a twin study |
| Q41522446 | Differentiation and apoptosis of human germinal center B-lymphocytes |
| Q52033249 | Differentiation of antitumor-specific cytotoxic T lymphocytes from autologous tumor infiltrating lymphocytes in non-Hodgkin's lymphomas. |
| Q73481235 | Direct cell/cell communication in the lymphoid germinal center: connexin43 gap junctions functionally couple follicular dendritic cells to each other and to B lymphocytes |
| Q40631718 | Disposition of recombinant human interleukin-10 in subjects with various degrees of renal function |
| Q44514354 | Distinct immune profiles characterize patients with diffuse or limited systemic sclerosis |
| Q34008997 | Down-regulated NOD2 by immunosuppressants in peripheral blood cells in patients with SLE reduces the muramyl dipeptide-induced IL-10 production. |
| Q71808672 | Dual action of IL-4 on mite antigen-induced IgE synthesis in lymphocytes from individuals with bronchial asthma |
| Q37932437 | Dual biological effects of the cytokines interleukin-10 and interferon-γ. |
| Q35225048 | Dysregulated production of interleukin-10 (IL-10) and IL-12 by peripheral blood lymphocytes from human immunodeficiency virus-infected individuals is associated with altered proliferative responses to recall antigens. |
| Q74254637 | Effect of B-cell receptor engagement on CD40-stimulated B cells |
| Q71549301 | Effect of IL-10 on collagen-induced arthritis in mice |
| Q40549286 | Effect of corticosteroids in addition to intravenous gamma globulin therapy on serum cytokine levels in the acute phase of Kawasaki disease in children |
| Q34764360 | Effect of intravitreal methotrexate and rituximab on interleukin-10 levels in aqueous humor of treated eyes with vitreoretinal lymphoma. |
| Q74506084 | Effect of oxatomide on T-cell activation and the production of interferon-gamma in mite sensitive asthma |
| Q36245748 | Effect of pregnancy on serum cytokines in SLE patients |
| Q47416460 | Effective induction of immune tolerance by portal venous infusion with IL-10 gene-modified immature dendritic cells leading to prolongation of allograft survival |
| Q41468042 | Effects of Th1 and Th2 cytokines on cytokine production and ICAM-1 expression on synovial fibroblasts |
| Q47809781 | Effects of intravenous immunoglobulin on plasma interleukin-10 levels in Kawasaki disease |
| Q42845326 | Effects of low-dose-gamma rays on the immune system of different animal models of disease |
| Q30452141 | Effects of virally expressed interleukin-10 on vaccinia virus infection in mice. |
| Q53482249 | Efficient preparation of human monoclonal antibody-secreting heterohybridomas using peripheral B lymphocytes cultured in the CD40 system |
| Q56906260 | Elevated CTLA-4 expression on CD4 T cells from periodontitis patients stimulated with Porphyromonas gingivalis outer membrane antigen |
| Q35891633 | Elevated serum IL-10 levels in diffuse large B-cell lymphoma: a mechanism of aberrant JAK2 activation |
| Q73276327 | Elevated vitreous interleukin-10 level is not diagnostic of intraocular-central nervous system lymphoma |
| Q41200759 | Endogenous interleukin-10 in inflammatory disorders: regulatory roles and pharmacological modulation |
| Q54537940 | Endomorphin-2 modulates productions of TNF-alpha, IL-1beta, IL-10, and IL-12, and alters functions related to innate immune of macrophages. |
| Q33595061 | Enriched protein screening of human bone marrow mesenchymal stromal cell secretions reveals MFAP5 and PENK as novel IL-10 modulators |
| Q36137341 | Epstein-Barr virus IL-10 engages IL-10R1 by a two-step mechanism leading to altered signaling properties |
| Q34123985 | Epstein-Barr virus lytic infection contributes to lymphoproliferative disease in a SCID mouse model |
| Q36655338 | Epstein-Barr virus recombinants with specifically mutated BCRF1 genes |
| Q36361303 | Epstein-Barr virus transformation induces B lymphocytes to produce human interleukin 10. |
| Q38947326 | Escherichia coli specific secretory IgA and cytokines in human milk from mothers of different ethnic groups resident in northern Italy |
| Q37446487 | Essential role of MALT1 protease activity in activated B cell-like diffuse large B-cell lymphoma. |
| Q37420414 | Establishment of an immunoglobulin m antibody-forming cell response model for characterizing immunotoxicity in primary human B cells |
| Q34491431 | Estrogen enhances immunoglobulin production by human PBMCs |
| Q35174152 | Etiology and pathogenesis of AIDS-related non-Hodgkin's lymphoma |
| Q34308324 | Etiopathogenesis of periodontitis in children and adolescents |
| Q39639722 | Evaluating the association of interleukin-10 gene promoter -592 A/C polymorphism with lupus nephritis susceptibility |
| Q34762084 | Evidence for a modulatory effect of IL-10 on both Th1 and Th2 cytokine production: the role of the environment |
| Q90407626 | Evidence for a pathogenic role of extrafollicular, IL-10-producing CCR6+B helper T cells in systemic lupus erythematosus |
| Q52977778 | Evidence for conformationally different states of interleukin-10: binding of a neutralizing antibody enhances accessibility of a hidden epitope. |
| Q41491995 | Evidence for the production and action of interleukin-10 in pituitary cells |
| Q24647705 | Exogenous ghrelin modulates release of pro-inflammatory and anti-inflammatory cytokines in LPS-stimulated macrophages through distinct signaling pathways |
| Q48756638 | Expression and significance of leukocyte membrane cofactor protein transcript in systemic lupus erythematosus |
| Q40794736 | Expression of Epstein-Barr virus (EBV) transcripts encoding homologues to important human proteins in diverse EBV associated diseases. |
| Q52927400 | Expression of IL-10 in Th memory lymphocytes is conditional on IL-12 or IL-4, unless the IL-10 gene is imprinted by GATA-3. |
| Q49534097 | Expression of Tumor Necrosis Factor Receptor 2 Characterizes TLR9-Driven Formation of Interleukin-10-Producing B Cells |
| Q38320708 | Expression of a 32‐kDa ligand for the CD40 antigen on activated human T lymphocytes |
| Q74300203 | Expression of and responses to CD2 and CD3 in 18-month-old children with and without atopic dermatitis |
| Q73191483 | Expression of fas (CD95) ligand is correlated with IL-10 and granulocyte colony-stimulating factor expression in oral and oropharyngeal squamous cell carcinoma |
| Q33679837 | Expression of functional immunomodulatory and anti-inflammatory factors in human milk. |
| Q42448855 | Expression of interleukin-10 by in vitro and in vivo activated hepatic stellate cells |
| Q64380196 | Extended lung expression and increased tissue localization of viral IL-10 with adenoviral gene therapy |
| Q33317619 | Extracorporeal shock waves down-regulate the expression of interleukin-10 and tumor necrosis factor-alpha in osteoarthritic chondrocytes |
| Q52682253 | FOXC1, the new player in the cancer sandbox. |
| Q33411534 | Factors determining the outcome of children hospitalized with severe pneumonia |
| Q34994340 | Fc-glycosylation of IgG1 is modulated by B-cell stimuli |
| Q45723572 | Feline Immunodeficiency Virus-Mediated Viral Interleukin-10 Gene Transfer Prolongs Non-Vascularized Cardiac Allograft Survival |
| Q35683668 | Fighting a losing battle: vigorous immune response countered by pathogen suppression of host defenses in the chytridiomycosis-susceptible frog Atelopus zeteki |
| Q36302329 | Follicular B helper T cells in antibody responses and autoimmunity. |
| Q38812644 | Follicular helper T cell in immunity and autoimmunity |
| Q75211744 | Frequencies at three polymorphic sites of interleukin-10 gene promoter in Brazilian renal recipients |
| Q27008912 | From IL-2 to IL-37: the expanding spectrum of anti-inflammatory cytokines |
| Q64097340 | Function and dysfunction of plasma cells in intestine |
| Q24651335 | Functional regions of the mouse interleukin-10 receptor cytoplasmic domain |
| Q34725058 | Functional validation of genes implicated in lymphomagenesis: an in vivo selection assay using a Myc-induced B-cell tumor |
| Q73954931 | Ganglioside GD1a enhances immunoglobulin production by human peripheral blood mononuclear cells |
| Q73074015 | Ganglioside GD1b supresses immunoglobulin production by human peripheral blood mononuclear cells |
| Q77419363 | Ganglioside GT1b suppresses immunoglobulin production by human peripheral blood mononuclear cells |
| Q37209917 | Gender and sex hormones in multiple sclerosis pathology and therapy. |
| Q41711827 | Gene expression, biological effects and clinical aspects of lymphokines |
| Q24289017 | Gene polymorphisms in chronic periodontitis |
| Q34686430 | Genetic Variants of Interleukin-10 Gene Promoter are Associated with Schizophrenia in Saudi Patients: A Case-Control Study |
| Q74471851 | Genetic association between interleukin-10 gene promoter region polymorphisms and type 1 diabetes age-at-onset |
| Q54387052 | Genetic predisposition to parthenium dermatitis in an Indian cohort due to lower-producing genotypes of interleukin-10 (-) 1082 G>A and (-) 819 C>T loci but no association with interferon-γ (+) 874 A>T locus. |
| Q36661811 | Genetic risk factors for inhibitors to factors VIII and IX. |
| Q37963581 | Genetic susceptibility to periodontitis |
| Q33893349 | Genetics of systemic lupus erythematosus. Clinical implications |
| Q34590595 | Genomic cloning and sequence analysis of Interleukin-10 from Labeo rohita. |
| Q39516450 | Gram-positive bacteria are potent inducers of monocytic interleukin-12 (IL-12) while gram-negative bacteria preferentially stimulate IL-10 production |
| Q37687316 | Grp94 in complexes with IgG is a soluble diagnostic marker of gastrointestinal tumors and displays immune-stimulating activity on peripheral blood immune cells. |
| Q33404468 | Gut health immunomodulatory and anti-inflammatory functions of gut enzyme digested high protein micro-nutrient dietary supplement-Enprocal |
| Q36895399 | HIV-induced IL-6/IL-10 dysregulation of CD4 cells is associated with defective B cell help and autoantibody formation against CD4 cells |
| Q56950294 | Harnessing T Follicular Helper Cell Responses for HIV Vaccine Development |
| Q27013680 | Herpesvirus exploitation of host immune inhibitory pathways |
| Q72863965 | High IgE secretion capacity of human plasma cells |
| Q48019620 | High levels of circulating IL-10 in human malaria |
| Q41276664 | High-level IL-10 production by monoclonal antibody-stimulated human T cells |
| Q36367154 | Histamine selectively enhances human immunoglobulin E (IgE) and IgG4 production induced by anti-CD58 monoclonal antibody |
| Q28208331 | Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency |
| Q38000157 | Human B cell defects in perspective |
| Q40745132 | Human B cell interleukin 10. |
| Q36361959 | Human B cell precursors proliferate and express CD23 after CD40 ligation |
| Q62801176 | Human IL-19 regulates immunity through auto-induction of IL-19 and production of IL-10 |
| Q37888669 | Human T helper cells reactive with somatic bacterial antigens belong to the Th1 subset |
| Q51959307 | Human colostrum T lymphocytes and their effector cytokines actively aid the development of the newborn immune system. |
| Q28259057 | Human interleukin 10 induces naive surface immunoglobulin D+ (sIgD+) B cells to secrete IgG1 and IgG3 |
| Q35753497 | Human interleukin-10 expression in T/natural killer-cell lymphomas: association with anaplastic large cell lymphomas and nasal natural killer-cell lymphomas |
| Q44919704 | Human plasma cells express granzyme B. |
| Q33889455 | Hypomethylation of IL10 and IL13 promoters in CD4+ T cells of patients with systemic lupus erythematosus |
| Q22001503 | ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28 |
| Q36312982 | IL-10 -1082 SNP and IL-10 in primary CNS and vitreoretinal lymphomas |
| Q48172896 | IL-10 Paradoxically Promotes Autoimmune Neuropathy through S1PR1-Dependent CD4+ T Cell Migration |
| Q41029302 | IL-10 and IL-4 co-operate to normalize in vitro IgA production in IgA-deficient (IgAD) patients |
| Q37772082 | IL-10 and TNFalpha genotypes in SLE. |
| Q33850728 | IL-10 as a mediator in the HPA axis and brain |
| Q74666128 | IL-10 enhances B-cell IgE synthesis by promoting differentiation into plasma cells, a process that is inhibited by CD27/CD70 interaction |
| Q45862807 | IL-10 expression by CT26 colon carcinoma cells inhibits their malignant phenotype and induces a T cell-mediated tumor rejection in the context of a systemic Th2 response |
| Q47712238 | IL-10 expression in thyroid glands: protective or harmful role against thyroid autoimmunity? |
| Q77352709 | IL-10 expression is associated with the expression of platelet-derived endothelial cell growth factor and prognosis in oral and oropharyngeal carcinoma |
| Q34920423 | IL-10 gene polymorphisms and susceptibility to systemic lupus erythematosus: a meta-analysis |
| Q33888307 | IL-10 inhibits macrophage activation and proliferation by distinct signaling mechanisms: evidence for Stat3-dependent and -independent pathways |
| Q36366877 | IL-10 is necessary and sufficient for autoimmune diabetes in conjunction with NOD MHC homozygosity |
| Q37271034 | IL-10 is up-regulated in multiple cell types during viremic HIV infection and reversibly inhibits virus-specific T cells |
| Q73764374 | IL-10 production in multiple sclerosis patients, SLE patients and healthy controls: preliminary findings |
| Q46812391 | IL-10 promoter polymorphisms influence susceptibility to aGvHD and are associated with proportions of CD4+FoxP3+ lymphocytes in blood after hematopoietic stem cell transplantation. |
| Q80149194 | IL-10 regulation of lupus in the NZM2410 murine model |
| Q40746828 | IL-10 restricts memory T cell inflation during cytomegalovirus infection |
| Q50335919 | IL-10 suppresses cell surface CD23/Fc epsilon RII expression, not by enhancing soluble CD23 release, but by reducing CD23 mRNA expression in human monocytes. |
| Q39079393 | IL-10 up-regulates CCR5 gene expression in human monocytes. |
| Q35787352 | IL-10-induced gp130 expression in mouse mast cells permits IL-6 trans-signaling |
| Q89761222 | IL-21 in Conjunction with Anti-CD40 and IL-4 Constitutes a Potent Polyclonal B Cell Stimulator for Monitoring Antigen-Specific Memory B Cells |
| Q90322419 | IL10 deficiency promotes alveolar enlargement and lymphoid dysmorphogenesis in the aged murine lung |
| Q48219985 | IL10 receptor is a novel therapeutic target in DLBCLs. |
| Q90286262 | IL10 restrains autoreactive B cells in transgenic mice expressing inactive RAG1 |
| Q51035073 | IVIg Attenuates TLR-9 Activation in B Cells from SLE Patients |
| Q104073610 | Identification and characterization of antigen-specific CD4+ T cells targeting renally expressed antigens in human lupus nephritis with two independent methods |
| Q24315000 | Identification and functional characterization of a second chain of the interleukin-10 receptor complex |
| Q24309517 | Identification of a cDNA for a human high-molecular-weight B-cell growth factor |
| Q40022115 | Identification of genes deregulated during serum-free medium adaptation of a Burkitt's lymphoma cell line |
| Q99723670 | Identifying novel B-cell targets for chronic inflammatory autoimmune disease by screening of chemical probes in a patient-derived cell assay |
| Q37353515 | Imbalance towards Th1 predominance is associated with acceleration of lupus-like autoimmune syndrome in MRL mice. |
| Q34345549 | Immune escape of γ-herpesviruses from adaptive immunity |
| Q40602183 | Immune response against tumors. |
| Q40959127 | Immune-based therapies for treatment of HIV infection |
| Q35085513 | Immunity to liver stage malaria: considerations for vaccine design. |
| Q28084887 | Immunological function of Blimp-1 in dendritic cells and relevance to autoimmune diseases |
| Q37150868 | Immunoregulatory soluble CTLA-4 modifies effector T-cell responses in systemic lupus erythematosus |
| Q40934484 | Immunosuppressive and anti-inflammatory properties of interleukin 10. |
| Q33700550 | Impaired humoral immunity in X-linked lymphoproliferative disease is associated with defective IL-10 production by CD4+ T cells |
| Q36366415 | Impaired neutrophil response and CD4+ T helper cell 1 development in interleukin 6-deficient mice infected with Candida albicans |
| Q41065092 | In vitro culture of B-lymphocytes derived from Epstein-Barr-virus-associated posttransplant lymphoproliferative disease: cytokine production and effect of interferon-alpha |
| Q43796404 | In vitro cytokine production of TNFalpha and IL-13 correlates with acute liver transplant rejection |
| Q77579828 | In vitro production of IgG4 by peripheral blood mononuclear cells (PBMC): the contribution of committed B cells |
| Q53702693 | In vivo production of interleukin-10 by malignant cells in AIDS lymphomas. |
| Q34725050 | Inactivation of Myc in murine two-hit B lymphomas causes dormancy with elevated levels of interleukin 10 receptor and CD20: implications for adjuvant therapies |
| Q71069059 | Increase of intracellular calcium is the essential signal for the expression of CD40 ligand |
| Q70646324 | Increased expression of interferon-gamma in hyperplastic lymph nodes from HIV-infected patients |
| Q73128900 | Increased levels of circulating acetylcholine receptor (AChR)-reactive IL-10-secreting cells are characteristic for myasthenia gravis (MG) |
| Q73664184 | Increased synovial fluid levels of soluble CD23 are associated with an erosive status in rheumatoid arthritis (RA) |
| Q59548368 | Induction by anti-CD40 antibody or soluble CD40 ligand and cytokines of IgG, IgA and IgE production by B cells from patients with X-linked hyper IgM syndrome |
| Q33804544 | Induction of B-cell lymphoma by UVB radiation in p53 haploinsufficient mice |
| Q40877007 | Induction of chromosomal aberrations and growth-transformation of lymphoblastoid cell lines by inhibition of reactive oxygen species-induced apoptosis with interleukin-6. |
| Q28199765 | Induction, binding specificity and function of human ICOS |
| Q72687686 | Ineffective expression of CD40 ligand on cord blood T cells may contribute to poor immunoglobulin production in the newborn |
| Q37883443 | Inflamed gut mucosa: downstream of interleukin-10. |
| Q38169798 | Inflammatory and immune pathways in the pathogenesis of periodontal disease |
| Q42497733 | Inflammatory response in induced sputum mononuclear cells from patients with acute exacerbation of asthma |
| Q37684031 | Influence of interferon-alpha combined with chemo (radio) therapy on immunological parameters in pancreatic adenocarcinoma |
| Q92088185 | Influenza NG-34 T cell conserved epitope adjuvanted with CAF01 as a possible influenza vaccine candidate |
| Q53459609 | Inhibition of Interferon Regulatory Factor 4 Attenuates Acute Liver Allograft Rejection in Mice. |
| Q71754653 | Inhibition of the CD40-CD40ligand pathway prevents murine membranous glomerulonephritis |
| Q40412947 | Inhibitory receptors CD85j, LAIR-1, and CD152 down-regulate immunoglobulin and cytokine production by human B lymphocytes. |
| Q39914140 | Initiation of lytic DNA replication in Epstein-Barr virus: search for a common family mechanism. |
| Q38114912 | Insights into B cells and HIV-specific B-cell responses in HIV-infected individuals |
| Q41949101 | Interferon gamma inhibits interleukin 10 production by monocytes |
| Q40220332 | Interferon-γ, interleukin-10 and interferon-inducible protein 10 (CXCL10) as serum biomarkers for the early allograft dysfunction after liver transplantation |
| Q24319022 | Interleukin 10 (IL-10) upregulates functional high affinity IL-2 receptors on normal and leukemic B lymphocytes |
| Q42943035 | Interleukin 10 but not interleukin 4 is a natural suppressant of cutaneous inflammatory responses |
| Q42519209 | Interleukin 10 induced c-fos expression in human B cells by activation of divergent protein kinases |
| Q34234171 | Interleukin 10 induces B lymphocytes from IgA-deficient patients to secrete IgA. |
| Q42942120 | Interleukin 10 induces apoptotic cell death of B-chronic lymphocytic leukemia cells |
| Q36367452 | Interleukin 10 inhibits growth and granulocyte/macrophage colony-stimulating factor production in chronic myelomonocytic leukemia cells |
| Q35359662 | Interleukin 10 promoter region polymorphisms and susceptibility to advanced alcoholic liver disease |
| Q36361558 | Interleukin 10 protects mice from lethal endotoxemia |
| Q35579058 | Interleukin 10 treatment for rheumatoid arthritis |
| Q42075980 | Interleukin 13 is a B cell stimulating factor |
| Q35787936 | Interleukin-10 (IL-10) augments allograft arterial disease: paradoxical effects of IL-10 in vivo |
| Q43946365 | Interleukin-10 -1082 gene polymorphism and susceptibility to cervical cancer among Japanese women |
| Q50563241 | Interleukin-10 Production in Response to Amyloid-β Differs between Slow and Fast Decliners in Patients with Alzheimer's Disease. |
| Q40935346 | Interleukin-10 activates heat-shock protein 90beta gene expression |
| Q33647931 | Interleukin-10 and Gp130 cytokines in human multiple myeloma |
| Q40772002 | Interleukin-10 and cancer |
| Q34482930 | Interleukin-10 and transforming growth factor-beta promoter polymorphisms in allergies and asthma |
| Q47912619 | Interleukin-10 as a regulatory cytokine induced by cellular stress: molecular aspects |
| Q36517771 | Interleukin-10 concentration and coronary heart disease (CHD) event risk in the estrogen replacement and atherosclerosis (ERA) study |
| Q46299578 | Interleukin-10 down-regulates MHC class II alphabeta peptide complexes at the plasma membrane of monocytes by affecting arrival and recycling. |
| Q78524512 | Interleukin-10 expression after intramuscular DNA electrotransfer: kinetic studies |
| Q47605327 | Interleukin-10 from CD4+ follicular regulatory T cells promotes the germinal center response. |
| Q35187588 | Interleukin-10 from T cells, but not macrophages and granulocytes, is required for chronic disease in Leishmania mexicana infection |
| Q47763655 | Interleukin-10 gene expression and adult T-cell leukemia |
| Q74330009 | Interleukin-10 gene promoter polymorphism in Japanese patients with adult and early-onset periodontitis |
| Q41607039 | Interleukin-10 in non-Hodgkin's lymphoma |
| Q71552680 | Interleukin-10 in the vitreous of patients with primary intraocular lymphoma |
| Q28280073 | Interleukin-10 induces immunoglobulin G isotype switch recombination in human CD40-activated naive B lymphocytes |
| Q34235308 | Interleukin-10 inhibits apoptotic cell death in infectious mononucleosis T cells |
| Q72803272 | Interleukin-10 inhibits motility in murine and human B lymphocytes |
| Q52185000 | Interleukin-10 inhibits the in vitro proliferation of human activated leukemic CD5+ B-cells. |
| Q72345227 | Interleukin-10 inhibits the primary allogeneic T cell response to human epidermal Langerhans cells |
| Q34543328 | Interleukin-10 is expressed by bovine type 1 helper, type 2 helper, and unrestricted parasite-specific T-cell clones and inhibits proliferation of all three subsets in an accessory-cell-dependent manner. |
| Q35680472 | Interleukin-10 paradox: A potent immunoregulatory cytokine that has been difficult to harness for immunotherapy |
| Q33493389 | Interleukin-10 prevents spontaneous death of germinal center B cells by induction of the bcl-2 protein |
| Q41394260 | Interleukin-10 production by a B-cell line derived from human post-transplant lymphoproliferative disease |
| Q51972906 | Interleukin-10 promoter polymorphism in patients with rheumatoid arthritis. |
| Q47973471 | Interleukin-10 promoter polymorphisms in Southern Chinese patients with systemic lupus erythematosus |
| Q36860338 | Interleukin-10 promoter variants predict HPV-positive tumors and survival of squamous cell carcinoma of the oropharynx |
| Q52176801 | Interleukin-10 receptor signaling through the JAK-STAT pathway. Requirement for two distinct receptor-derived signals for anti-inflammatory action. |
| Q71120290 | Interleukin-10 regulation in normal subjects and patients with asthma |
| Q33876788 | Interleukin-10 responses to liver-stage antigen 1 predict human resistance to Plasmodium falciparum. |
| Q33340529 | Interleukin-10 suppression of myeloid cell activation--a continuing puzzle |
| Q38523956 | Interleukin-10 up-regulates tumour-necrosis-factor-alpha-related apoptosis-inducing ligand (TRAIL) gene expression in mammary epithelial cells at the involution stage |
| Q87165829 | Interleukin-10-1082 gene polymorphism is associated with papillary thyroid cancer |
| Q33723684 | Interleukin-10: an anti-inflammatory cytokine with therapeutic potential |
| Q41684151 | Interleukin-10: biology, role in inflammation and autoimmunity |
| Q36978831 | Interleukin-21 is a critical cytokine for the generation of virus-specific long-lived plasma cells. |
| Q36376711 | Interleukin-4 protects against a genetically linked lupus-like autoimmune syndrome |
| Q33745148 | Intragraft expression of the IL-10 gene is up-regulated in renal protocol biopsies with early interstitial fibrosis, tubular atrophy, and subclinical rejection |
| Q35309325 | Intravitreal chemotherapy for the treatment of recurrent intraocular lymphoma |
| Q34671059 | Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes |
| Q35056305 | Jun-regulated genes promote interaction of diffuse large B-cell lymphoma with the microenvironment. |
| Q50049788 | Kinetics of viral load and cytokines in severe fever with thrombocytopenia syndrome |
| Q44088405 | LF 15-0195 prevents from the development and inhibits the progression of rat experimental autoimmune myasthenia gravis |
| Q54175860 | Lack of association between interleukin-10, transforming growth factor-beta gene polymorphisms and juvenile-onset systemic lupus erythematosus. |
| Q56519367 | Lactobacilli from human gastrointestinal mucosa are strong stimulators of IL-12 production |
| Q45883107 | Lentivirus-mediated gene transfer of viral interleukin-10 delays but does not prevent cardiac allograft rejection. |
| Q35552804 | Lipopolysaccharide and monophosphoryl lipid A differentially regulate interleukin-12, gamma interferon, and interleukin-10 mRNA production in murine macrophages. |
| Q58698634 | Liposomal nanoparticle-based conserved peptide influenza vaccine and monosodium urate crystal adjuvant elicit protective immune response in pigs |
| Q90533216 | Logistic Regression Classification of Primary Vitreoretinal Lymphoma versus Uveitis by Interleukin 6 and Interleukin 10 Levels |
| Q41291605 | Long-term survival of heart and liver xenografts with splenectomy and FK 506 |
| Q42759877 | Low-grade B cell lymphomas of mucosa-associated lymphoid tissue (MALT-type) require CD40-mediated signaling and Th2-type cytokines for in vitro growth and differentiation |
| Q36329496 | M1 of Murine Gamma-Herpesvirus 68 Induces Endoplasmic Reticulum Chaperone Production |
| Q34299710 | Macrophage cytokines: involvement in immunity and infectious diseases |
| Q41965237 | Mapping of the interleukin-10/interleukin-10 receptor combining site |
| Q77905787 | Markers in the promoter region of interleukin-10 (IL-10) gene in myasthenia gravis: implications of diverse effects of IL-10 in the pathogenesis of the disease |
| Q41300802 | Masters of deception: a review of herpesvirus immune evasion strategies |
| Q33205985 | Mechanisms in prostatitis/chronic pelvic pain syndrome |
| Q40628597 | Mediation of Enhanced Transcription of the IL-10 Gene in T Cells, Upon Contact with Human Glioma Cells, by Fas Signaling Through a Protein Kinase A-Independent Pathway |
| Q35666602 | Melatonin and viral infections |
| Q43743683 | Melatonin treatment enhances the efficiency of mice immunization with Venezuelan equine encephalomyelitis virus TC-83. |
| Q34340937 | Microbe-dependent CD11b+ IgA+ plasma cells mediate robust early-phase intestinal IgA responses in mice |
| Q71686319 | Mimicking the humoral immune response in vitro results in antigen-specific isotype switching supported by specific autologous T helper cells: generation of human HIV-1-neutralizing IgG monoclonal antibodies from naive donors |
| Q91911071 | Mixing ratio optimization for functional complex extracts of Rhodiola crenulata, Panax quinquefolius, and Astragalus membranaceus using mixture design and verification of immune functional efficacy in animal models |
| Q42709515 | Modulation of mite antigen‐induced immune responses by lecithin‐bound iodine in peripheral blood lymphocytes from patients with bronchial asthma |
| Q42854644 | Modulation of systemic antigen-specific immune responses by oral antigen in humans. |
| Q28272127 | Modulation of the human cytokine response by interferon lambda-1 (IFN-lambda1/IL-29) |
| Q35296982 | Molecular biomarkers for the diagnosis of primary vitreoretinal lymphoma |
| Q40392133 | Molecular control of B Lymphocyte growth and differentiation |
| Q34331092 | Molecular pathology of primary intraocular lymphoma |
| Q73608318 | Monocyte-derived IL-10-secreting dendritic cells in choroid plexus epithelium |
| Q35747533 | Multiple mechanisms of immune suppression by B lymphocytes |
| Q45392613 | Multiple sclerosis: reduced proportion of circulating plasmacytoid dendritic cells expressing BDCA-2 and BDCA-4 and reduced production of IL-6 and IL-10 in response to herpes simplex virus type 1. |
| Q50903174 | Murine immunomodulation of IL-10 and IL-12 induced by new isolates from avian type 2 Lactobacillus acidophilus. |
| Q40918922 | Myasthenia gravis: selective enrichment of antiacetylcholine receptor antibody production in untransformed human B cell cultures |
| Q34285220 | NF-κB2 mutation targets survival, proliferation and differentiation pathways in the pathogenesis of plasma cell tumors |
| Q42517263 | Nasal epithelial cells express IL-10 at levels that negatively correlate with clinical symptoms in patients with house dust mite allergy |
| Q46418509 | Natural autoantibodies, IgG antibodies to tetanus toxoid and CD5+ B cells in patients with Mediterranean visceral leishmaniasis. The Leishmania Study Group |
| Q55041831 | Natural feline coronavirus infection: differences in cytokine patterns in association with the outcome of infection. |
| Q90214231 | Neonatal priming and infancy boosting with a novel respiratory syncytial virus vaccine induces protective immune responses without concomitant respiratory disease upon RSV challenge |
| Q35548444 | Neuropsychiatric systemic lupus erythematosus is associated with imbalance in interleukin 10 promoter haplotypes |
| Q92689063 | Neutralization of rhesus cytomegalovirus IL-10 reduces horizontal transmission and alters long-term immunity |
| Q57085803 | Neutralizing antibodies in multiple sclerosis patients treated with 375 μg interferon-β-1b |
| Q37409360 | Nonredundant roles for B cell-derived IL-10 in immune counter-regulation |
| Q37846865 | Novel regulatory functions for Toll-like receptor-activated B cells during intracellular bacterial infection |
| Q42611744 | Nucleotide sequence of a marsupial interleukin-10 cDNA from the Australian brushtail possum (Trichosurus vulpecula). |
| Q37403682 | Pathophysiology of retinal lymphoma |
| Q36190407 | Perspectives on common variable immune deficiency |
| Q50450148 | Phenotypic differences of CD4(+) T cells in response to red blood cell immunization in transfused sickle cell disease patients. |
| Q55266542 | Plasma Cell Differentiation Pathways in Systemic Lupus Erythematosus. |
| Q33856322 | Plasma cell generation from B-lymphocytes via CD27/CD70 interaction |
| Q45412251 | Plasmacytoid dendritic cells induce a distinct cytokine pattern in virus-specific CD4+ memory T cells that is modulated by CpG oligodeoxynucleotides |
| Q24317429 | Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6 |
| Q87876744 | Polymorphism of IL-10 receptor β affects the prognosis of multiple myeloma patients treated with thalidomide and/or bortezomib |
| Q35791655 | Possible mechanisms of gender bias in SLE: a new hypothesis involving a comparison of SLE with atopy |
| Q40985093 | Post-transplant lymphoproliferative disease (PTLD): lymphokine production and PTLD. |
| Q43620498 | Pre-erythrocytic immunity to Plasmodium falciparum: the case for an LSA-1 vaccine |
| Q35018126 | Preferential binding to Elk-1 by SLE-associated IL10 risk allele upregulates IL10 expression |
| Q42245915 | Prenatal vitamin A deficiency impairs adaptive immune responses to pentavalent rotavirus vaccine (RotaTeq®) in a neonatal gnotobiotic pig model |
| Q45365024 | Prevalence of Epstein-Barr virus in tonsils and adenoids of United Arab Emirates nationals |
| Q34875021 | Pro- and anti-inflammatory cytokines in human immunodeficiency virus infection and acquired immunodeficiency syndrome |
| Q41456685 | Production of interleukin-10 by human bronchogenic carcinoma. |
| Q35765267 | Production of the immunosuppressive cytokine interleukin-10 by Epstein-Barr-virus-expressing pyothorax-associated lymphoma: possible role in the development of overt lymphoma in immunocompetent hosts |
| Q41462121 | Proliferation and immunoglobulin secretion of lymphoblastoid cell lines are differently affected by soluble cytokines |
| Q72080497 | Purified excretory-secretory component of filarial parasite enhances Fc epsilon RII/CD23 expression on human splenic B and T cells and IgE synthesis while potentiating T-helper type 2-related cytokine generation from T cells |
| Q43196260 | Puumala virus RNA in patient with multiorgan failure |
| Q40231953 | Recombinant protein YbgF induces protective immunity against Rickettsia heilongjiangensis infection in C3H/HeN mice. |
| Q52007339 | Reduced IL-2-induced IL-12 responsiveness in atopic children. |
| Q82028854 | Regulation of T cells and cytokines by the interleukin-10 (IL-10)-family cytokines IL-19, IL-20, IL-22, IL-24 and IL-26 |
| Q42490503 | Regulation of immunoglobulin secretion by plasma cells infiltrating nasal polyps |
| Q28477869 | Regulation of interleukin-10 receptor ubiquitination and stability by beta-TrCP-containing ubiquitin E3 ligase |
| Q73958152 | Regulation of mouse immuno-responses by a natural suppressor cell clone from bone marrow |
| Q41827353 | Regulation of production of mucosal antibody to pneumococcal protein antigens by T-cell-derived gamma interferon and interleukin-10 in children. |
| Q35685566 | Regulatory B10 cells differentiate into antibody-secreting cells after transient IL-10 production in vivo |
| Q34430587 | Relationship of Epstein-Barr virus and interleukin 10 promoter polymorphisms with the risk and clinical outcome of childhood Burkitt lymphoma. |
| Q73401710 | Repeated concanavalin A challenge in mice induces an interleukin 10-producing phenotype and liver fibrosis |
| Q37360750 | Requirement for increased IL-10 in the development of B-1 lymphoproliferative disease in a murine model of CLL. |
| Q54560299 | Retinoic acid enhances the production of IL-10 while reducing the synthesis of IL-12 and TNF-alpha from LPS-stimulated monocytes/macrophages. |
| Q34572250 | Rheumatoid arthritis and tumor necrosis factor alpha |
| Q71608295 | Role of CD40 antigen and interleukin-2 in T cell-dependent human B lymphocyte growth |
| Q90411093 | Role of Epstein-Barr Virus in Pathogenesis and Racial Distribution of IgA Nephropathy |
| Q38176006 | Role of IL-10 in the progression of kidney disease |
| Q40237247 | Role of Interleukin-10 Gene Promoter Region Polymorphism in the Development of Chronic Lymphoid Leukemia. |
| Q56834786 | Role of Interleukin-10 in the Lung Response to Silica in Mice |
| Q36476646 | Role of TLR2-dependent IL-10 production in the inhibition of the initial IFN-γ T cell response to Porphyromonas gingivalis. |
| Q35986928 | Role of cytokines in systemic lupus erythematosus: recent progress from GWAS and sequencing |
| Q36364479 | Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus |
| Q40403592 | Role of interleukin-4 and interleukin-13 in synthesis of IgE and expression of CD23 by human B cells |
| Q38060836 | Roles of IL-10 in ocular inflammations: a review. |
| Q36677337 | STAT3-mediated up-regulation of BLIMP1 Is coordinated with BCL6 down-regulation to control human plasma cell differentiation. |
| Q24300242 | Same structure, different function crystal structure of the Epstein-Barr virus IL-10 bound to the soluble IL-10R1 chain |
| Q46758920 | Secretion of parasite-specific immunoglobulin G by purified blood B lymphocytes from immune individuals after in vitro stimulation with recombinant Plasmodium falciparum merozoite surface protein-119 antigen |
| Q35080072 | Selective activation of human dendritic cells by OM-85 through a NF-kB and MAPK dependent pathway |
| Q73899142 | Selective enhancement of endothelial cell VCAM-1 expression by interleukin-10 in the presence of activated leucocytes |
| Q61955175 | Serum IL-4, IL-10 and IL-6 levels in inflammatory arthritis |
| Q33561191 | Serum adiponectin as a predictor of childhood non-Hodgkin's lymphoma: a nationwide case-control study. |
| Q78099939 | Serum cytokines and increased total serum IgE in alcoholics |
| Q57332478 | Serum free light chains, interferon-alpha, and interleukins in systemic lupus erythematosus |
| Q57194426 | Serum interleukin 10 titers in systemic lupus erythematosus reflect disease activity |
| Q73202043 | Serum interleukin-10 in plasma-cell dyscrasias |
| Q73363940 | Serum levels of tetranectin, intercellular adhesion molecule-1 and interleukin-10 in B-chronic lymphocytic leukemia |
| Q33951480 | Sex hormones as immunomodulators in health and disease |
| Q34333361 | Sex hormones in experimental autoimmune encephalomyelitis: implications for multiple sclerosis |
| Q41332745 | Sex hormones modulate the immune response to Plasmodium berghei ANKA in CBA/Ca mice |
| Q33828605 | Short-lived IFN-γ effector responses, but long-lived IL-10 memory responses, to malaria in an area of low malaria endemicity |
| Q34199490 | Signaling through CD40 rescues IgE but not IgG or IgA secretion in X-linked immunodeficiency with hyper-IgM. |
| Q51743751 | Skin disease is prevented but nephritis is accelerated by multiple pregnancies in autoimmune MRL/LPR mice. |
| Q24669982 | Soluble and membrane-bound forms of signaling lymphocytic activation molecule (SLAM) induce proliferation and Ig synthesis by activated human B lymphocytes |
| Q45138741 | Spontaneous apoptosis of dendritic cells is efficiently inhibited by TRAP (CD40-ligand) and TNF-alpha, but strongly enhanced by interleukin-10. |
| Q73833450 | Spontaneous expression of mRNA for IL-10, GM-CSF, TGF-beta, TGF-alpha, and IL-6 in peripheral blood mononuclear cells from atopic dermatitis |
| Q38351898 | Stat3 recruitment by two distinct ligand-induced, tyrosine-phosphorylated docking sites in the interleukin-10 receptor intracellular domain |
| Q38272620 | Stimulation of B lymphocytes by cmvIL-10 but not LAcmvIL-10 |
| Q35925869 | Structural analysis of IL-10 and Type I interferon family members and their complexes with receptor |
| Q48350871 | Structural characterisation of the distal 5' flanking region of the human interleukin-10 gene |
| Q75231227 | Studies in NZB IL-10 knockout mice of the requirement of IL-10 for progression of B-cell lymphoma |
| Q45734684 | Suppressive effect of locally produced interleukin-10 on respiratory syncytial virus infection |
| Q33181349 | Switch from cyclosporine A to tacrolimus in renal transplant recipients: impact on Th1, Th2, and monokine responses |
| Q77394096 | Synergistic augmentative effect of interleukin-10 and CD27/CD70 interactions on B-cell immunoglobulin synthesis |
| Q38743752 | Synergy of interleukin 10 and toll-like receptor 9 signalling in B cell proliferation: Implications for lymphoma pathogenesis. |
| Q37645635 | Systemic Lupus Erythematosus: Old and New Susceptibility Genes versus Clinical Manifestations |
| Q56906331 | Systemic lupus erythematosus candidate genes in the Italian population: evidence for a significant association with interleukin-10 |
| Q36673286 | Systemic lupus erythematosus: multiple immunological phenotypes in a complex genetic disease. |
| Q35558638 | T cell subsets and their signature cytokines in autoimmune and inflammatory diseases |
| Q35828841 | T cell-dependent survival of CD20+ and CD20- plasma cells in human secondary lymphoid tissue. |
| Q42747570 | T cells of the human intestinal lamina propria are high producers of interleukin-10. |
| Q45730577 | T-helper I immunity, specific for the breast cancer antigen insulin-like growth factor-I receptor (IGF-IR), is associated with increased adiposity |
| Q43493525 | T-helper cell-mediated interferon-gamma, interleukin-10 and proliferation responses to a candidate recombinant vaccine for human parvovirus B19. |
| Q37235039 | TLR-mediated stimulation of APC: Distinct cytokine responses of B cells and dendritic cells. |
| Q82627959 | TLR4 and MyD88 control protection and pulmonary granulocytic recruitment in a murine intranasal RSV immunization and challenge model |
| Q36071989 | TLR9 agonists induced cell death in Burkitt's lymphoma cells is variable and influenced by TLR9 polymorphism |
| Q37350439 | TNFA and IL10 gene polymorphisms are not associated with periodontitis in Brazilians. |
| Q37483143 | TRAF3 regulates the effector function of regulatory T cells and humoral immune responses |
| Q45944049 | Targeting IL-10 Family Cytokines for the Treatment of Human Diseases. |
| Q99588210 | Targeting of interleukin-10 receptor by a potential human interleukin-10 peptide efficiently blocks interleukin-10 pathway-dependent cell proliferation |
| Q42467538 | Th1 (IL-2, interferon-gamma (IFN-gamma)) and Th2 (IL-10, IL-4) cytokine production by peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE). |
| Q24673258 | The CD40, CTLA-4, thyroglobulin, TSH receptor, and PTPN22 gene quintet and its contribution to thyroid autoimmunity: back to the future |
| Q33882153 | The Epstein-Barr virus and its association with human cancers |
| Q35046770 | The IL-10 polarized cytokine pattern in innate and adaptive immunity cells contribute to the development of FVIII inhibitors |
| Q33326982 | The MHV68 M2 protein drives IL-10 dependent B cell proliferation and differentiation |
| Q34942368 | The Mycobacterium tuberculosis complex-restricted gene cfp32 encodes an expressed protein that is detectable in tuberculosis patients and is positively correlated with pulmonary interleukin-10. |
| Q47134266 | The Role of the Transcription Factor Ets1 in Lupus and Other Autoimmune Diseases |
| Q33187279 | The TNF family members BAFF and APRIL: the growing complexity |
| Q36667866 | The absence of M1 leads to increased establishment of murine gammaherpesvirus 68 latency in IgD-negative B cells |
| Q40385754 | The biology of the human ligand for CD40. |
| Q34203672 | The complex role of interleukin-10 in autoimmunity |
| Q52049146 | The differentiation of human memory B cells into specific antibody-secreting cells is CD40 independent. |
| Q38281273 | The dual nature of interleukin-10 in pemphigus vulgaris |
| Q73294557 | The effect of smokeless tobacco extract on murine T cell cytokine production |
| Q42520842 | The effects of CD40- and interleukin (IL-4)-activated CD23+ cells on the production of IL-10 by mononuclear cells in Graves' disease: the role of CD8+ cells |
| Q34148175 | The genetics of systemic lupus erythematosus: putting the pieces together |
| Q34315400 | The human interleukin-10 receptor gene maps to chromosome 11q23.3. |
| Q46061551 | The immune modulation of B-cell responses by Porphyromonas ginginvalis and interleukin-10. |
| Q83346423 | The immune modulation of Bacillus cereus var. Toyoi in mice immunized with experimental inactivated Bovine Herpesvirus Type 5 vaccine |
| Q35548182 | The immune suppressive effect of dexamethasone in rheumatoid arthritis is accompanied by upregulation of interleukin 10 and by differential changes in interferon gamma and interleukin 4 production |
| Q35809008 | The immunoregulatory and allergy-associated cytokines in the aetiology of the otitis media with effusion |
| Q41761209 | The immunosuppressive factors IL-10, TGF-β, and VEGF do not affect the antigen-presenting function of CD40-activated B cells |
| Q51084911 | The interplay between T helper subset cytokines and IL-12 in directing human B lymphocyte differentiation. |
| Q35810601 | The molecular basis of IL-10 function: from receptor structure to the onset of signaling |
| Q41853009 | The normal counterpart of IgD myeloma cells in germinal center displays extensively mutated IgVH gene, Cmu-Cdelta switch, and lambda light chain expression |
| Q40816643 | The p38 mitogen-activated kinase pathway regulates the human interleukin-10 promoter via the activation of Sp1 transcription factor in lipopolysaccharide-stimulated human macrophages |
| Q40603032 | The potential role of cytokines in the pathogenesis of Epstein-Barr virus associated post-transplant lymphoproliferative disease |
| Q37951500 | The regulation and role of T follicular helper cells in immunity |
| Q38956578 | The role of IL-29 in immunity and cancer. |
| Q37811046 | The role of SAP and SLAM family molecules in the humoral immune response |
| Q26775041 | The role of cytokines in the pathogenesis and staging of Trypanosoma brucei rhodesiense sleeping sickness |
| Q36703956 | The role of genetic polymorphisms in periodontitis |
| Q34148661 | The role of interleukin-10 in autoimmune disease: systemic lupus erythematosus (SLE) and multiple sclerosis (MS). |
| Q34203678 | The role of interleukin-10 in systemic lupus erythematosus |
| Q38298670 | The vIL-10 gene of the Epstein-Barr virus (EBV) is conserved in a stable manner except for a few point mutations in various EBV isolates |
| Q34767204 | Theodore E. Woodward Award: development of novel, EBV-targeted therapies for EBV-positive tumors |
| Q53650475 | Therapeutic effects of systemic vitamin k2 and vitamin d3 on gingival inflammation and alveolar bone in rats with experimentally induced periodontitis. |
| Q40779579 | Tracking membrane and secretory immunoglobulin alpha heavy chain mRNA variation during B-cell differentiation by real-time quantitative polymerase chain reaction. |
| Q34430041 | Trichodysplasia spinulosa-associated polyomavirus (TSV) and Merkel cell polyomavirus: correlation between humoral and cellular immunity stronger with TSV |
| Q71941651 | Tumor necrosis factor-alpha, lymphotoxin, interleukin (IL)-6, IL-10, IL-12 and perforin mRNA expression in mononuclear cells in response to acetylcholine receptor is augmented in myasthenia gravis |
| Q35787792 | Tumor-associated transforming growth factor-beta and interleukin-10 contribute to a systemic Th2 immune phenotype in pancreatic carcinoma patients |
| Q33606814 | Type I (insulin-dependent) diabetes is a Th1- and Th2-mediated autoimmune disease |
| Q28554673 | Type I Interferons Induce T Regulatory 1 Responses and Restrict Humoral Immunity during Experimental Malaria |
| Q80109609 | Ultraviolet-A (UVA-1) radiation suppresses immunoglobulin production of activated B lymphocytes in vitro |
| Q36362069 | Viral interleukin 10 is critical for the induction of B cell growth transformation by Epstein-Barr virus |
| Q30436621 | Virus-encoded homologs of cellular interleukin-10 and their control of host immune function |
| Q38120519 | Why interleukin-10 supplementation does not work in Crohn's disease patients. |
| Q36911289 | vIL-10-overexpressing human MSCs modulate naïve and activated T lymphocytes following induction of collagenase-induced osteoarthritis |
Search more.